0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > B7-H3

B7-H3

B7-H3 Molecule Information

Name:CD276 antigen
Target Synonym:Costimulatory molecule?4Ig-B7-H3?B7 homolog 3?B7H3?B7-H3?CD276
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:6
Lastest Research Phase:Phase ?

B7-H3 Protein Product ListCompare or Buy

Cat. No. Species Product Description Structure Purity Feature
B73-C52Ha Cynomolgus Cynomolgus B7-H3 / CD276 Protein, His Tag
B73-C52Ha-structure
B73-C52Ha-sds
B73-C52Ha-elisa_1
B73-H82F5 Human Biotinylated Human B7-H3 / CD276 Protein, Fc,Avitag™
B73-H82F5-structure
B73-H82F5-sds
B73-H82F5-elisa_1
B73-H82E6 Human Biotinylated Human B7-H3 / CD276 Protein, Avitag™,His Tag
B73-H82E6-structure
B73-H82E6-sds
B73-H82E6-elisa_1
B73-M52H4 Mouse Mouse B7-H3 / CD276 Protein, His Tag
B73-M52H4-structure
B73-M52H4-sds
B73-M5255 Mouse Mouse B7-H3 / CD276 Protein, Fc Tag
B73-M5255-structure
B73-M5255-sds
B73-H52E2 Human Human B7-H3 / CD276 Protein, His Tag
B73-H52E2-structure
B73-H52E2-sds
B73-H52E2-elisa_1
B73-H5253 Human Human B7-H3 / CD276 Protein, Fc Tag
B73-H5253-structure
B73-H5253-sds
B73-H5253-elisa_1

B7-H3 Molecule Synonym Name

B7-H3,CD276,B7 homolog 3

B7-H3 Molecule Background

B7 homolog 3 (B7-H3), a member of the immunoglobulin superfamily, is also known CD276, which contains two Ig-like C2-type (immunoglobulin-like) domains and two Ig-like V-type (immunoglobulin-like) domains. B7-H3 may participate in the regulation of T-cell-mediated immune response. B7-H3 also plays a protective role in tumor cells by inhibiting natural-killer mediated cell lysis as well as a role of marker for detection of neuroblastoma cells. Furthermore, B7-H3 is involved in the development of acute and chronic transplant rejection and in the regulation of lymphocytic activity at mucosal surfaces. It could also play a key role in providing the placenta and fetus with a suitable immunological environment throughout pregnancy.

B7-H3 References

B7-H3 Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Monoclonal antibody 8H9 I-131 131-I-8H9; 8H9-MAb; 131I-8H9-(B7-H3) Phase Ⅱ Memorial Sloan-Kettering Cancer Center, Y-mAbs Central nervous system cysticercosis, Peritoneum cancer Details
DS-5573 DS-5573; DS-5573a Phase Ⅰ Daiichi Sankyo Solid tumours Details
Enoblituzumab MGA-271,MGA271 Phase Ⅱ MacroGenics Prostate cancer Details
Monoclonal antibody 8H9 I-124 124I-8H9; 124I-8H9-(B7-H3) Phase Ⅱ Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College Glioma Details
MGC-018 MGC-018 Phase Ⅱ MacroGenics Solid tumours Details
Orlotamab MGD-009; B7-H3 x CD3 Phase Ⅰ MacroGenics Solid tumours Details

This web search service is supported by Google Inc.

totop